课题基金 / 基金详情

THE BIOLOGY AND UTILITY SIRT1- MEDIATED NEUROPROTECTION

THE BIOLOGY AND UTILITY SIRT1- MEDIATED NEUROPROTECTION
生物学和实用性 SIRT1 介导的神经保护
批准号:
7085094
负责人:
DAVID A. SINCLAIR
金额:
$31.12万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-04-01 至 2011-03-31

项目摘要

项目成果

DAVID A. SINCLAIR的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
There is a significant unmet medical need for therapies to treat neurodegenerative disorders. Alzheimer's disease (AD) and Huntington's disease (HD), for example, have no cure or even an effective treatment. These two diseases alone cost the US healthcare system $100+ billion a year. SIRT1 is a member of the sirtuin family of NAD+-dependent deacetylases, which are thought to have evolved very early in life's history to enhance an organism's chances of surviving adversity and may underlie the neuroprotection and other health benefits provided by caloric restriction (CR). Hyperactivation of SIRT1 is responsible for the remarkable ability of neurons to survive long afer being cut in the case of the Wallerian mouse mutant (WldS). We and others have also found that SIRT1 protects neurons against death and dysfunction in models for HD, AD and ALS. Resveratrol (a SIRT1-activating molecule) or "STAC" can significantly delay neurodegeneration and cognitive decline in the p25-Tg mouse model of AD. Our lab has generated 20+ analogs of resveratrol, some of which have improved stability and potency. We have also generated the first SIRT1 tissue-specific inducible transgenic mouse. In this proposal, we will investigate the mechanism by which SIRT1 provides protection against neurodegeneration and test whether SIRT1 activation can delay the progression of different two neurodegenerative disorders, namely AD and HD using mouse genetic models. Preliminary experiments indicate that SIRT1 works by suppressing apoptosis and increasing DNA repair, the latter of which is emerging as a possible contributor to brain aging and a variety of neurodegenerative disorders. The STACs and SIRT1 transgenic animals we have generated place us in a unique position to be able to test these hypotheses. Lay description: Ten percent of Americans over the age of 65 suffer from Alzheimer's disease, a disease estimated to cost approximately $100 billion annually. The SIRT1 protein is considered by many to possibly be a master regulator of the body's innate defenses against disease and debilitation. SIRT1 is somehow able to keep neurons healthy and alive when they would otherwise die. We aim to uncover the mechanism by which S1RT1 protects neurons and to develop molecules that stimulate the SIRT1 protein and provide protection against a variety of neurodegenerative diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Using cellular co-biosis and age programmable mice to derive a global interaction map of aging hallmarks
  • 批准号:
    10721454
  • 项目类别:
  • 资助金额:
    $45.36万
  • 财政年份:
    2023
  • 负责人:
    DAVID A. SINCLAIR
  • 依托单位:
Tagmentation-based Indexing for Methylation Sequencing as a novel method of high-throughput methylation clock measurement
  • 批准号:
    10273233
  • 项目类别:
  • 资助金额:
    $62.63万
  • 财政年份:
    2021
  • 负责人:
    DAVID A. SINCLAIR
  • 依托单位:
Nicotinamide Mononucleotide (NMN) as a Novel Therapeutic in the Treatment of Oral Mucositis
  • 批准号:
    9770831
  • 项目类别:
  • 资助金额:
    $21.19万
  • 财政年份:
    2018
  • 负责人:
    DAVID A. SINCLAIR
  • 依托单位:
Uncovering the Human Secretome
  • 批准号:
    9344966
  • 项目类别:
  • 资助金额:
    $118.65万
  • 财政年份:
    2017
  • 负责人:
    DAVID A. SINCLAIR
  • 依托单位:
国内基金
海外基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
  • 批准号:
    81000622
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2010
  • 负责人:
    梁胜
  • 依托单位:
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
  • 批准号:
    31060293
  • 项目类别:
    地区科学基金项目
  • 资助金额:
    26.0万元
  • 批准年份:
    2010
  • 负责人:
    郭亚芬
  • 依托单位:
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究